PBM

Propel Bio Management Portfolio holdings

AUM $117M
1-Year Est. Return 64.07%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+64.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$117M
AUM Growth
+$17.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$5.28M
2
+$4.95M
3
+$4.65M
4
OCS icon
Oculis Holding
OCS
+$3.46M
5
PHAT icon
Phathom Pharmaceuticals
PHAT
+$2.68M

Top Sells

1
+$10.9M
2
+$6.83M
3
+$3.52M
4
JSPR icon
Jasper Therapeutics
JSPR
+$2.45M
5
MIST icon
Milestone Pharmaceuticals
MIST
+$2.17M

Sector Composition

1 Healthcare 79.21%
2 Energy 20.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAGP icon
1
Plains GP Holdings
PAGP
$4.54B
$24.4M 20.79%
1,272,360
ACHV icon
2
Achieve Life Sciences
ACHV
$244M
$18.8M 16.07%
3,786,425
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$924M
$12.3M 10.49%
740,918
+187,991
VRDN icon
4
Viridian Therapeutics
VRDN
$2.87B
$8.79M 7.51%
282,531
+192,531
MIST icon
5
Milestone Pharmaceuticals
MIST
$146M
$8.32M 7.1%
4,118,321
-1,006,569
KYTX icon
6
Kyverna Therapeutics
KYTX
$498M
$6.27M 5.35%
+666,666
CMPS
7
Compass Pathways
CMPS
$803M
$5.95M 5.08%
861,778
+351,778
IVA
8
Inventiva
IVA
$1.3B
$4.65M 3.97%
+1,000,000
DCTH icon
9
Delcath Systems
DCTH
$313M
$4.43M 3.78%
438,509
ABEO icon
10
Abeona Therapeutics
ABEO
$276M
$4.38M 3.74%
830,780
-143,242
CLDX icon
11
Celldex Therapeutics
CLDX
$2.01B
$4.19M 3.58%
154,300
-700
NKTR icon
12
Nektar Therapeutics
NKTR
$1.91B
$3.5M 2.99%
82,822
+33,822
OCS icon
13
Oculis Holding
OCS
$1.64B
$3.45M 2.95%
+172,839
SABS icon
14
SAB Biotherapeutics
SABS
$190M
$2.44M 2.08%
+652,881
RGNX icon
15
Regenxbio
RGNX
$477M
$1.68M 1.44%
+116,896
LONA
16
LeonaBio Inc
LONA
$52.4M
$1.13M 0.96%
149,279
LENZ
17
LENZ Therapeutics
LENZ
$444M
$945K 0.81%
+59,085
AARD
18
Aardvark Therapeutics
AARD
$120M
$609K 0.52%
+46,408
ZVRA icon
19
Zevra Therapeutics
ZVRA
$511M
$571K 0.49%
63,683
-168,191
KLRS
20
Kalaris Therapeutics
KLRS
$196M
$355K 0.3%
+42,053
AKRO
21
DELISTED
Akero Therapeutics
AKRO
– –
-228,884
APLT
22
DELISTED
Applied Therapeutics
APLT
– –
-11,285,420
JSPR icon
23
Jasper Therapeutics
JSPR
$37.5M
– –
-1,028,806
TCRX icon
24
TScan Therapeutics
TCRX
$59M
– –
-1,932,304